Navigation Links
PharMEDium Elects William R. Spalding to Board of Directors
Date:8/25/2010

LAKE FOREST, Ill., Aug. 25 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors.

Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services firm that applies extensive operational, financial and transactional expertise to assist companies primarily in the healthcare services industry.  Jonas stated, "Bill's experience in the healthcare services industry and his expertise with respect to matters of strategy, corporate development, operations and governmental affairs equip him well to add value to PharMEDium as a member of our Board of Directors going forward.  He will be an asset."

Mr. Spalding's career experience includes EVP Strategy and Managed Care for CVSCaremark Inc., a Fortune 20 company, and Senior Partner in the Atlanta office of King & Spalding LLP, where he led the Private Equity & Investment Funds Practice and was a member of the firm's management committee.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter <797>, and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
5. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
8. University of California Los Angeles Selects Velos eResearch
9. Spherix Elects New Independent Director, and Elects Chairman of the Board
10. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete ... for clients that rely on safety and cleanliness. This unique flooring system uses ... has been used for centuries for its antimicrobial properties. Unlike antibiotics, which kill ...
(Date:9/20/2017)... Houston, TX (PRWEB) , ... September 20, 2017 ... ... the date of the much-anticipated fall event , Look Awesome This Autumn ... demonstrations, personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic Trainers ... Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, evidence ... Athletic Trainers are acknowledged by their peers with accolades and highly prestigious awards. ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t ... risk of price gouging for their prescription drugs, according to a new comparison ... isn’t negotiating on our behalf, there’s no consistency in drug pricing among drug ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the ... in an average life. This mouse sets out on a journey that will show ... Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has ...
Breaking Medicine News(10 mins):